The long non‐coding RNA PVT1 represses ANGPTL4 transcription through binding with EZH2 in trophoblast cell
Trophoblast
DOI:
10.1111/jcmm.13405
Publication Date:
2017-11-29T17:34:41Z
AUTHORS (9)
ABSTRACT
Abstract Despite progress in diagnostics and treatment for preeclampsia, it remains the foremost cause of maternal foetal perinatal morbidity mortality worldwide. Over recent years, various lines evidence have emphasized long non‐coding RNA s (lnc s) which function as an innovative regulator biological behaviour, exemplified by proliferation, apoptosis metastasis. However, role lnc has not been well described preeclampsia. Here, we identified a , PVT 1 whose expression was down‐regulated qRT ‐ PCR analyses severe The effects on development were studied after suppression overexpression HTR ‐8/ SV neo JEG 3 cells. knockdown notably inhibited cell proliferation stimulated cycle accumulation apoptosis. Exogenous significantly increased proliferation. Based analysis seq data, found that could affect numerous genes, then investigated regulatory mechanism trophoblast Further mechanistic implied action is moderately attributable to its repression ANGPTL 4 via association with epigenetic repressor Ezh2. Altogether, our study suggests play essential preeclampsia progression probably acts latent therapeutic marker; thus, might be useful prognostic marker when evaluating new therapies patients
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (46)
CITATIONS (47)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....